	Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI. J Appl Clin Med Phys Do DD, Conlin CC, Bagrodia A, Cooperberg M, Hahn ME, Harisinghani M, Hollenberg G, Javier-Desloges J, Kamran SC, Kane CJ, Lee KL, Liss MA, Margolis DJA, Murphy PM, Nakrour N, Ohliger MA, Osinski T, Rakow-Penner R, Domingo MR, Salmasi A, Shabaik AS, Song Y, Trecarten S, Wehrli N, Weinberg EP, Woolen S, Dale AM, Seibert TM. PMID: 41854856 [PubMed - indexed for MEDLINE]
	Novel radiopharmaceuticals for bladder cancer evaluation. Q J Nucl Med Mol Imaging Guglielmo P, Perrone E, Librando M, Aghaee A, Sadeghpour S, Nicolosi S, Kovic A, Mapelli P, Evangelista L. PMID: 41854639 [PubMed - as supplied by publisher]
	[The prostate biopsy during the follow-up of a cohort of 400,000 asymptomatic men undergoing PSA testing in the Agency for Health Protection of the Metropolitan Area of Milan]. Epidemiol Prev Buzzoni C, Crocetti E, Frammartino B, Cereda D, Russo AG. PMID: 41854000 [PubMed - indexed for MEDLINE]
	[Follow-up management after PSA testing in 400,000 citizens within the Agency for Health Protection of the Metropolitan Area of Milan]. Epidemiol Prev Frammartino B, Crocetti E, Buzzoni C, Cereda D, Russo AG. PMID: 41853999 [PubMed - indexed for MEDLINE]
	[Prostate cancer screening. Fragmented prevention: from prescription to diagnostic pathway]. Epidemiol Prev Russo AG. PMID: 41853996 [PubMed - in process]
	Case Report: A rare case of primary undifferentiated pleomorphic sarcoma of the renal pelvis with high PD-L1 expression and a misleading positive urine FISH. Front Immunol Li J, Wang X, Zhen J, Qi M. PMID: 41853282 [PubMed - indexed for MEDLINE]
	An efficient automated approach for accumulated dose estimation in prostate cancer radiotherapy. Phys Imaging Radiat Oncol Grohmann M, Krug D, Baehr A, Petersen C, Todorovic M, Schäfer S, Böckelmann LC, Gargioni E. PMID: 41853125 [PubMed]
	Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway. Chin J Cancer Res Wang Z, Wang J, Chen S, Wu R, Tuo Z, Ye L, Yoo KH, Li D, Jin X, Xiong W, Feng D. PMID: 41852923 [PubMed]
	Corrigendum to "Stigma experiences among young and middle-aged testicular cancer survivors in China: A phenomenological study" [Asia Pac J Oncol Nurs 13 (2026) 100825]. Asia Pac J Oncol Nurs Zhao Y, Li D, Zhang M, Yan W, Shen H, Xu M, Liu Y. PMID: 41852758 [PubMed]
	Dyadic coping, relationship quality, and psychosocial adaption between couples facing prostate cancer: A longitudinal cross-lagged study. Asia Pac J Oncol Nurs Yuan X, Chen M, Zhang T, Sun Z, Yang Z, Yin H, Yang Y. PMID: 41852754 [PubMed]
	Prognostic Significance of Radiographic Progression at Metastatic Castration-Resistant Prostate Cancer Diagnosis. Int J Urol Iwamoto H, Hori T, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Yaegashi H, Nohara T, Shigehara K, Izumi K, Mizokami A. PMID: 41852124 [PubMed - indexed for MEDLINE]
	Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study. Prostate Cancer Prostatic Dis Shore ND, George DJ, Khan N, Constantinovici N, Chen G, Ghadessi M, Hlebec V, Morgans AK. PMID: 41851476 [PubMed - as supplied by publisher]
	Introducing Key Performance Metrics for Assessing the Benefits and Harm of the Prostate Cancer Diagnostic Pathway. Eur Urol Oncol Padhani AR, Carlsson S, Bratt O, Schoots IG. PMID: 41850940 [PubMed - as supplied by publisher]
	The Impact of Early Postoperative Urinary Incontinence on Presenteeism After Robot-Assisted Radical Prostatectomy for Prostate Cancer: A Prospective Cohort Study. Low Urin Tract Symptoms Nakayama N, Tsuji T, Kumagai A. PMID: 41850893 [PubMed - indexed for MEDLINE]
	Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression). Magn Reson Med Sci Nakanishi K, Tanaka J, Tanaka Y, Yano K, Hongyo H, Maeda N, Sakai M, Tateishi S, Yamane Y, Kashiwagi N, Konishi K, Nagahara A, Nakayama M, Nishimura K, Takenaka S, Okada A, Kudo A, Yuzawa T, Tomiyama N. PMID: 41850822 [PubMed - as supplied by publisher]
	Prognostic Factors and Oncological Outcomes after Trimodality Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer: A Multicenter Real-World Study. Actas Urol Esp (Engl Ed) Feltes Benítez N, Couñago F, Paredes-Rubio S, Peleteiro Higuero P, Molina Osorio JG, Folgar Torres A, Aissati A, Mera A, Pastor Peidró JR, Garrido Botella MI, González de Dueñas M, Duque-Santana V, Torices Caballero J, Pons Sánchez A, Andreescu Yagüe J, Rodríguez Pérez A, Guardado González S, Fernández Alonso S, Lazo-Prados A, Gaztañaga Boronat M, Moreno López S, Méndez Villamón A, García Gómez R, Gil Restrepo C, Alonso Martínez P, Mesa López F, Ibáñez Villoslada C, Willisch Santamaría P, Ribeiro I, Nicolás Boluda C, Fernández López J, López Campos F, Sargos P, González Del Portillo E. PMID: 41850565 [PubMed - as supplied by publisher]
	Editorial Comment: "Mental Health Burden of a Testicular Cancer Diagnosis: Insights from a Large Claims Database". Urology Callahan DM, Laviana AA. PMID: 41850338 [PubMed - as supplied by publisher]
	Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol Chang JCW, Nandakumar S, Stopsack KH, Fong C, Pichotta K, Jee J, Woo HJ, Donoghue MTA, Vasselman S, Barnett E, Autio KA, Danila D, McHugh D, Morris M, Rathkopf D, Scher H, Slovin S, Kantoff P, Gopalan A, Solit DB, Wibmer A, Schultz N, Abida W. PMID: 41849730 [PubMed - indexed for MEDLINE]
	Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer. J Clin Oncol Valle LF, Calais J, Kishan AU. PMID: 41849721 [PubMed - as supplied by publisher]
	Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer. J Clin Oncol Bölek H, Ürün Y. PMID: 41849717 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176924

Page 1 of 8847



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy